Joanna F. Collingwood

Prof. Joanna F. Collingwood

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2007 in Neurology
Verified
Journal Article
Closed access
PDF file
AOA. E. Oakley
A. E. Oakley
JCJoanna F. Collingwood
Joanna F. Collingwood
JDJon Dobson
Jon Dobson
GLG. Love
G. Love
HPH. R. Perrott
H. R. Perrott
CMC. M. Morris
C. M. Morris
Objective: Evidence suggests that abnormal iron metabolism is associated with Parkinson disease (PD), with raised iron levels found in pathologically affected areas in PD. It is unknown if this elevated iron is actually associated with neurons or reactive glia, and we therefore addressed this issue by determining if raised iron was present in single dopaminergic neurons. Methods: We used unfixed frozen sections from postmortem tissue of PD patients and elderly normal individuals to avoid metal contamination and translocation. Levels of iron and other elements were measured using sensitive and specific wavelength dispersive electron probe x-ray microanalysis coupled with cathodoluminescence spectroscopy in individual substantia nigra dopaminergic neurons. Results: We identified raised intraneuronal iron in single defined substantia nigra neurons in PD (mean neuronal iron 2,838 vs 1,611, p < 0.0001) but not in other movement disorders such as Huntington disease. These findings were unrelated to the density of remaining neurons. Conclusions: Primary changes in neuronal iron could lead to neurodegeneration in Parkinson disease.

3 June 2004 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
EHEmily House
Emily House
JCJoanna F. Collingwood
Joanna F. Collingwood
AKAyesha Khan
Ayesha Khan
OKOlga Korchazkina
Olga Korchazkina
GBGuy Berthon
Guy Berthon
CEChristopher Exley
Christopher Exley
Metals are found associated with β-pleated sheets of Aβ42 in vivo and may be involved in their formation. Metal chelation has been proposed as a therapy for Alzheimer's disease on the basis that it may safely dissolve precipitated Aβ peptides. We hav

1 October 2017 in Cell Chemical Biology
Verified
Journal Article
Open access
Neil TellingNeil Telling
Neil Telling
JEJames Everett
James Everett
JCJoanna F. Collingwood
Joanna F. Collingwood
JDJon Dobson
Jon Dobson
GLGerrit van der Laan
Gerrit van der Laan
AHAdam P. Hitchcock
Adam P. Hitchcock
A signature characteristic of Alzheimer's disease (AD) is aggregation of amyloid-beta (Aβ) fibrils in the brain. Nevertheless, the links between Aβ and AD pathology remain incompletely understood. It has been proposed that neurotoxicity arising from aggregation of the Aβ1-42 peptide can in part be explained by metal ion binding interactions. Using advanced X-ray microscopy techniques at sub-micron resolution, we investigated relationships between iron biochemistry and AD pathology in intact cortex from an established mouse model over-producing Aβ. We found a direct correlation of amyloid plaque morphology with iron, and evidence for the formation of an iron-amyloid complex. We also show that iron biomineral deposits in the cortical tissue contain the mineral magnetite, and provide evidence that Aβ-induced chemical reduction of iron could occur in vivo. Our observations point to the specific role of iron in amyloid deposition and AD pathology, and may impact development of iron-modifying therapeutics for AD.

6 June 2014 in Journal of The Royal Society Interface
Verified
Journal Article
Open access
JEJ. Everett
J. Everett
ECEva Céspedes
Eva Céspedes
LSL. R. Shelford
L. R. Shelford
CEChristopher Exley
Christopher Exley
JCJoanna F. Collingwood
Joanna F. Collingwood
Neil TellingNeil Telling
Neil Telling
For decades, a link between increased levels of iron and areas of Alzheimer's disease (AD) pathology has been recognized, including AD lesions comprised of the peptide β-amyloid (Aβ). Despite many observations of this association, the relationship between Aβ and iron is poorly understood. Using X-ray microspectroscopy, X-ray absorption spectroscopy, electron microscopy and spectrophotometric iron(II) quantification techniques, we examine the interaction between Aβ(1–42) and synthetic iron(III), reminiscent of ferric iron stores in the brain. We report Aβ to be capable of accumulating iron(III) within amyloid aggregates, with this process resulting in Aβ-mediated reduction of iron(III) to a redox-active iron(II) phase. Additionally, we show that the presence of aluminium increases the reductive capacity of Aβ, enabling the redox cycling of the iron. These results demonstrate the ability of Aβ to accumulate iron, offering an explanation for previously observed local increases in iron concentration associated with AD lesions. Furthermore, the ability of iron to form redox-active iron phases from ferric precursors provides an origin both for the redox-active iron previously witnessed in AD tissue, and the increased levels of oxidative stress characteristic of AD. These interactions between Aβ and iron deliver valuable insights into the process of AD progression, which may ultimately provide targets for disease therapies.

1 November 2013 in NeuroImage
Verified
Journal Article
Closed access
FSF.M. Skidmore
F.M. Skidmore
MYM. Yang
M. Yang
LBL. Baxter
L. Baxter
KDK. von Deneen
K. von Deneen
JCJoanna F. Collingwood
Joanna F. Collingwood
YLY. Liu
Y. Liu

28 April 2016 in Scientific Reports
Verified
Journal Article
Open access
GPGermán Plascencia-Villa
Germán Plascencia-Villa
Arturo PonceArturo Ponce
Arturo Ponce
JCJoanna F. Collingwood
Joanna F. Collingwood
MAM. Josefina Arellano-Jiménez
M. Josefina Arellano-Jiménez
XZXiongwei Zhu
Xiongwei Zhu
George PerryGeorge Perry
George Perry
Abnormal accumulation of brain metals is a key feature of Alzheimer’s disease (AD). Formation of amyloid-β plaque cores (APC) is related to interactions with biometals, especially Fe, Cu and Zn, but their particular structural associations and roles remain unclear. Using an integrative set of advanced transmission electron microscopy (TEM) techniques, including spherical aberration-corrected scanning transmission electron microscopy (Cs-STEM), nano-beam electron diffraction, electron holography and analytical spectroscopy techniques (EDX and EELS), we demonstrate that Fe in APC is present as iron oxide (Fe3O4) magnetite nanoparticles. Here we show that Fe was accumulated primarily as nanostructured particles within APC, whereas Cu and Zn were distributed through the amyloid fibers. Remarkably, these highly organized crystalline magnetite nanostructures directly bound into fibrillar Aβ showed characteristic superparamagnetic responses with saturated magnetization with circular contours, as observed for the first time by off-axis electron holography of nanometer scale particles.